The European Medicines Association (EMA) has upheld its decision to recommend the Alzheimer’s drug lecanemab despite concerns that any clinical benefits are small and there is a risk of brain swelling ...

Patients’ safety is being compromised because a growing number of doctors are feeling severely tired at work, medical defence experts have warned. The Medical Defence Union (MDU) said that longer ...

Vani Sethi and colleagues highlight country efforts on evidence based policy making, strengthening implementation and ...

Vani Sethi and colleagues consider the barriers to implementing policies to improve the nutrition of adolescent girls in South Asia and how they can be overcome Poor nutrition among adolescent girls ...

Collaboration with adolescent girls can help overcome the structural barriers to good nutrition, say Noor ul Emam and Yashfa Abid Good health and nutrition go beyond knowing what to eat. We must make ...

Regional cross sectoral action is a policy imperative Roughly half of the population in South Asia is under 18 years of age, with a staggering 350 million adolescents living in the South Asia region.1 ...

Urgent action is required to tackle the rising prevalence of overweight and obesity among adolescent girls in South Asia by improving food environments and countering the influence of powerful ...

Efforts to reduce nutritional inequity among adolescent girls in South Asia need to be reinforced by legal frameworks, argue Zivai Murira and colleagues Good nutrition is essential for health, ...

Seema Khadka and colleagues highlight how better digital access can contribute to better nutrition for girls South Asia has the world’s largest gender gap in mobile internet access. Adolescent boys ...

Multifaceted actions are needed to better identify and challenge underlying patriarchal and socioeconomic factors affecting ...

Actively challenging racism takes courage, Abi Rimmer hears “Racism, in all forms, has no place in healthcare. However, it does exist, and it leaves a devastating impact on colleagues and patients and ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...